Abelson J L, Weg J G, Nesse R M, Curtis G C (1996) Neuroendocrine reponses to laboratory panic: cognitive intervention in the doxapram model . Psychoneuroendocrinology21: 375-390
2.
Bailey J E, Argyropoulus S V, Lightman S L, Nuff D J (2003) Does the brain noradrenaline network mediate the effects of the CO2 challenge? J Psychopharmacol17: 252-259
3.
Bertani A, Perna G, Migliarese G, Di Pasquale D, Bellodi L (2003) Comparison of treatment with paroxetine and reboxetine in panic disorder. A randomized, single-blind study . J Clin Psychiatry, in press
4.
Caldirola D, Bellodi L, Caumo A, Migliarese G, Perna G (2003) Approximate Entropy of respiratory patterns in Panic Disorder . Am J Psychiatry, in press
5.
Perna G, Bertani A, Caldirola D, Di Pasquale D, Migliarese G, Bellodi L (2003) Modulation of hyperactivity to 35% CO2 after one-week of treatment with paroxetine and reboxetine: a double-blind, randomized study . J Clin Psychopharmacol, in press
6.
Shina S S, Coplan J D, Pine D S, Martinez J A, Klein D F, Gorman J M (1999) Panic induced by carbon dioxide inhalation and lack of hypothalamo-pituitary-adrenal axis activation . Psychiatry Res86: 93-98
